Study: Common asthma drug slashes Covid hospitalisation by 90%
Posted by freedomforall 4 years, 2 months ago to Business
"Budesonide, which is sold as Pulmicort, also shortens recovery times from the infection, according to new research.
Asthma drug budesonide, sold as Pulmicort, reduces the likelihood of needing hospital care for Covid, a study has found
The steroid is typically given to people with asthma and chronic obstructive pulmonary disease (COPD) and is sold under the name Pulmicort.
Pulmicort is inhaled through a puffer, but budesonide also comes in tablets, granules or rectal foam for a range of conditions, according to the NHS.
Oxford researchers were keen to study the medicine when they noticed few people with chronic respiratory disease going to hospital for Covid in the first wave.
They were often prescribed the steroid drug - originally made by the firm AstraZeneca, which also makes Oxford's Covid vaccine.
In the STOIC study, half of the 146 participants were given budesonide within seven days of having coronavirus symptoms.
The 28-day study found those who inhaled the drug had a 90 per cent reduced risk of urgent care or hospitalisation compared to those on "usual care"."
The study:
https://www.medrxiv.org/content/10.11...
Asthma drug budesonide, sold as Pulmicort, reduces the likelihood of needing hospital care for Covid, a study has found
The steroid is typically given to people with asthma and chronic obstructive pulmonary disease (COPD) and is sold under the name Pulmicort.
Pulmicort is inhaled through a puffer, but budesonide also comes in tablets, granules or rectal foam for a range of conditions, according to the NHS.
Oxford researchers were keen to study the medicine when they noticed few people with chronic respiratory disease going to hospital for Covid in the first wave.
They were often prescribed the steroid drug - originally made by the firm AstraZeneca, which also makes Oxford's Covid vaccine.
In the STOIC study, half of the 146 participants were given budesonide within seven days of having coronavirus symptoms.
The 28-day study found those who inhaled the drug had a 90 per cent reduced risk of urgent care or hospitalisation compared to those on "usual care"."
The study:
https://www.medrxiv.org/content/10.11...
